PMID- 37890103 OWN - NLM STAT- MEDLINE DCOM- 20231030 LR - 20231216 IS - 1935-5548 (Electronic) IS - 0149-5992 (Print) IS - 0149-5992 (Linking) VI - 46 IP - 11 DP - 2023 Nov 1 TI - The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis. PG - 2076-2083 LID - 10.2337/dc23-1015 [doi] AB - BACKGROUND: Moderate alcohol use may be associated with lower risk of type 2 diabetes mellitus (T2DM). Previous reviews have reached mixed conclusions. PURPOSE: To quantify the dose-response relationship between alcohol consumption and T2DM, accounting for differential effects by sex and BMI. DATA SOURCES: Medline, Embase, Web of Science, and one secondary data source. STUDY SELECTION: Cohort studies on the relationship between alcohol use and T2DM. DATA EXTRACTION: Fifty-five studies, and one secondary data source, were included with a combined sample size of 1,363,355 men and 1,290,628 women, with 89,983 and 57,974 individuals, respectively, diagnosed with T2DM. DATA SYNTHESIS: Multivariate dose-response meta-analytic random-effect models were used. For women, a J-shaped relationship was found with a maximum risk reduction of 31% (relative risk [RR] 0.69, 95% CI 0.64-0.74) at an intake of 16 g of pure alcohol per day compared with lifetime abstainers. The protective association ceased above 49 g per day (RR 0.82, 95% CI 0.68-0.99). For men, no statistically significant relationship was identified. When results were stratified by BMI, the protective association was only found in overweight and obese women. LIMITATIONS: Our analysis relied on aggregate data. We included some articles that determined exposure and cases via self-report, and the studies did not account for temporal variations in alcohol use. CONCLUSIONS: The observed reduced risk seems to be specific to women in general and women with a BMI >/=25 kg/m2. Our findings allow for a more precise prediction of the sex-specific relationship between T2DM and alcohol use, as our results differ from those of previous studies. CI - (c) 2023 by the American Diabetes Association. FAU - Llamosas-Falcon, Laura AU - Llamosas-Falcon L AUID- ORCID: 0000-0003-4718-9376 AD - Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. FAU - Rehm, Jurgen AU - Rehm J AD - Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. AD - Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. AD - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. AD - Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. AD - Institute of Clinical Psychology and Psychotherapy & Center of Clinical Epidemiology and Longitudinal Studies (CELOS), Technische Universitat Dresden, Dresden, Germany. AD - Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. AD - Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. FAU - Bright, Sophie AU - Bright S AD - School of Health and Related Research (ScHARR), Faculty of Medicine, Dentistry & Health, University of Sheffield, Sheffield, U.K. FAU - Buckley, Charlotte AU - Buckley C AD - Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, U.K. FAU - Carr, Tessa AU - Carr T AD - Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. FAU - Kilian, Carolin AU - Kilian C AD - Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. FAU - Lasserre, Aurelie M AU - Lasserre AM AD - Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland. FAU - Lemp, Julia M AU - Lemp JM AD - Heidelberg Institute of Global Health, Medical Faculty and University Hospital, University of Heidelberg, Heidelberg, Germany. FAU - Zhu, Yachen AU - Zhu Y AD - Alcohol Research Group, Public Health Institute, Emeryville, CA. FAU - Probst, Charlotte AU - Probst C AD - Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. AD - Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. AD - Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. AD - Heidelberg Institute of Global Health, Medical Faculty and University Hospital, University of Heidelberg, Heidelberg, Germany. LA - eng GR - R01 AA028009/AA/NIAAA NIH HHS/United States GR - R01AA028009/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Meta-Analysis PT - Research Support, N.I.H., Extramural PT - Review PT - Systematic Review PL - United States TA - Diabetes Care JT - Diabetes care JID - 7805975 SB - IM MH - Male MH - Humans MH - Female MH - *Diabetes Mellitus, Type 2/epidemiology MH - Risk Factors MH - Body Mass Index MH - Alcohol Drinking/adverse effects/epidemiology MH - Cohort Studies PMC - PMC10620538 COIS- Duality of Interest. No potential conflicts of interest relevant to this article were reported. EDAT- 2023/10/27 18:42 MHDA- 2023/10/30 06:46 PMCR- 2024/11/01 CRDT- 2023/10/27 15:53 PHST- 2023/06/01 00:00 [received] PHST- 2023/08/26 00:00 [accepted] PHST- 2024/11/01 00:00 [pmc-release] PHST- 2023/10/30 06:46 [medline] PHST- 2023/10/27 18:42 [pubmed] PHST- 2023/10/27 15:53 [entrez] AID - 153773 [pii] AID - 231015 [pii] AID - 10.2337/dc23-1015 [doi] PST - ppublish SO - Diabetes Care. 2023 Nov 1;46(11):2076-2083. doi: 10.2337/dc23-1015.